![]() |
市場調查報告書
商品編碼
1755963
2032 年外用藥物包裝市場預測:按產品類型、性質、包裝材料、劑型、最終用戶和地區進行的全球分析Topical Drugs Packaging Market Forecasts to 2032 - Global Analysis By Product Type (Plastic Bottles, Caps & Closures, Inhalers, Plastic Tubes, Glass Bottles), Nature, Packaging Material, Mode of Administration, End User and By Geography |
根據 Stratistics MRC 的數據,全球外用藥物包裝市場預計在 2025 年達到 55 億美元,到 2032 年將達到 104 億美元,預測期內的複合年成長率為 9.4%。
外用藥物包裝是指專為用於皮膚或黏膜給藥而設計的容器和給藥系統。這些容器包括管、瓶、幫浦和貼劑,旨在保護藥物穩定性、確保劑量精準並防止污染。包裝材料的選擇應與活性成分相容,並提供阻隔水分、光線和空氣的屏障,以保持藥物的功效和保存期限。
根據世界衛生組織 (WHO) 的數據,全球約有 23 億人患有皮膚病,因此對高效包裝以便於使用的皮膚病治療藥物的需求日益成長。
先進封裝技術
包裝技術的進步是外用藥物包裝市場的關鍵驅動力。材料、分配機制和阻隔性能的創新正在提升產品的安全性、功效和使用者便利性。新的包裝解決方案能夠更好地防止污染、防潮和避光,並延長保存期限。包裝設計的不斷發展增強了外用藥物製劑的保護性和易用性。在追求卓越產品完整性的驅動下,技術進步是包裝創新的驅動力。
材料相容性成本高
高昂的材料相容性成本是外用藥物包裝市場的一個顯著限制因素。外用藥物由於其活性藥物成分 (API) 和輔料的特性,可能與某些包裝材料發生不良反應,導致藥效降低或改變。需要進行廣泛的測試,以確保包裝材料不會滲入產品或吸附活性成分,這既昂貴又耗時。如此嚴格的兼容性評估會產生大量的開發成本。嚴格的材料相容性要求背後的成本仍然是一項重大挑戰。
個性化醫療的發展
個人化醫療的成長為外用藥物包裝市場帶來了巨大的機會。隨著治療方案越來越貼合每位患者的個別情況,外用製劑對靈活、小批量、客製化包裝解決方案的需求日益成長。這包括單劑量包裝、專用施用器以及可容納不同劑量的包裝。精準醫療格局的不斷發展為包裝創新開闢了新的途徑。在個人化醫療客製化需求的推動下,新的包裝解決方案正在出現。
仿冒藥品包裝
假藥包裝對外用藥包裝市場構成重大威脅。假冒外用藥的增多,通常含有不合格或有害成分,直接影響病人安全和品牌聲譽。造假者常使用模仿正品的包裝,使消費者難以區分仿冒品。保護供應鏈和確保產品真實性是該行業面臨的關鍵挑戰。面對猖獗的假威脅,安全包裝至關重要。
新冠疫情對外用藥物包裝市場產生了多方面的影響。人們越來越關注個人衛生和外用防腐藥物,而供應鏈中斷則影響了某些包裝材料的可得性。藥品採購向電子商務的轉變也增加了對用於直接面對消費者配送的堅固安全包裝的需求。總體而言,市場已展現出應對不斷變化的消費行為和物流挑戰的適應能力。受供應鏈需求變化的觸發,疫情再形成了包裝的優先順序。
預計塑膠瓶市場在預測期內將佔據最大佔有率
市場佔有率。由於其用途廣泛且廣受歡迎,塑膠瓶仍然是主要的包裝形式。
預計在預測期內,液體部分將以最高的複合年成長率成長。
在預測期內,液體外用製劑(例如消毒劑、藥用洗液和皮膚病治療液)預計將達到最高成長。噴霧瓶和專用滴管等液體製劑包裝技術的創新提高了其可用性。隨著對便捷有效的液體外用製劑的需求不斷成長,該細分市場預計將大幅成長。液體外用製劑應用範圍的不斷擴大正推動該細分市場實現顯著成長。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於該地區人口眾多、醫療支出不斷成長以及製藥製造業的蓬勃發展。此外,當地製藥公司和受託製造廠商的擴張也有助於推動該地區市場的發展。在蓬勃發展的製藥業和龐大的消費群的支持下,亞太地區已在市場上佔據領先地位。
預計北美地區在預測期內將呈現最高的複合年成長率。這得益於大型製藥公司的佈局、對新型藥物輸送系統研發的強勁投入以及先進包裝解決方案的廣泛採用。對專業化和個人化外用藥物日益成長的需求進一步推動了市場擴張。此外,嚴格的藥品包裝監管規範也推動了技術創新和高品質材料的採用。在藥品包裝技術持續創新的推動下,北美市場可望迎來強勁成長。
According to Stratistics MRC, the Global Topical Drugs Packaging Market is accounted for $5.5 billion in 2025 and is expected to reach $10.4 billion by 2032 growing at a CAGR of 9.4% during the forecast period. Topical drug packaging refers to specialized containers and delivery systems for medications applied to the skin or mucous membranes. These include tubes, bottles, pumps, or patches designed to protect the drug's stability, ensure precise dosing, and prevent contamination. Packaging materials are chosen for compatibility with active ingredients, providing barriers against moisture, light, and air to maintain efficacy and shelf life.
According to the World Health Organization (WHO), around 2.3 billion people globally suffer from skin diseases, thus contributing to the growing need for dermatological drugs that are packaged efficiently for ease of use.
Advancements in packaging technology
Advancements in packaging technology are a significant driver for the topical drugs packaging market. Innovations in materials, dispensing mechanisms, and barrier properties are enhancing product safety, efficacy, and user convenience. New packaging solutions offer improved protection against contamination, moisture, and light, extending shelf life. This continuous evolution in packaging design provides better protection and enhanced usability for topical drug formulations. Fueled by the pursuit of superior product integrity, technological advancements drive packaging innovation
High material compatibility costs
High material compatibility costs present a notable restraint for the topical drugs packaging market. Topical drugs, due to their active pharmaceutical ingredients (APIs) and excipients, can interact negatively with certain packaging materials, leading to degradation or altered efficacy. Extensive testing is required to ensure that packaging materials do not leach into the product or adsorb active ingredients, which can be costly and time-consuming. This rigorous compatibility assessment adds significant development costs. Backed by stringent material compatibility requirements, costs remain a significant challenge.
Growth in personalized medicine
Growth in personalized medicine represents a significant opportunity for the topical drugs packaging market. As treatments become more tailored to individual patients, there is a growing need for flexible, small-batch, and customized packaging solutions for topical formulations. This includes unit-dose packaging, specialized applicators, and packaging that can accommodate varying dosages. This evolving landscape of precision healthcare creates new avenues for packaging innovation. Propelled by the customization needs of personalized medicine, new packaging solutions emerge.
Counterfeit drug packaging
Counterfeit drug packaging poses a substantial threat to the topical drugs packaging market. The rise of counterfeit topical drugs, often with substandard or harmful ingredients, directly impacts patient safety and brand reputation. Counterfeiters often use packaging that mimics genuine products, making it difficult for consumers to distinguish between authentic and fake medications. Protecting the supply chain and ensuring product authenticity is a critical industry challenge. Influenced by the pervasive threat of counterfeiting, secure packaging is paramount.
The COVID-19 pandemic had a mixed impact on the topical drugs packaging market. While there was an increased focus on personal hygiene and antiseptic topical products, supply chain disruptions affected the availability of certain packaging materials. The shift towards e-commerce for pharmaceutical purchases also increased the demand for robust and secure packaging for direct-to-consumer delivery. Overall, the market demonstrated adaptability in response to changing consumer behavior and logistical challenges. Triggered by evolving supply chain demands, the pandemic reshaped packaging priorities.
The plastic bottles segment is expected to be the largest during the forecast period
The plastic bottles segment is expected to account for the largest market share during the forecast period, due to the versatility, cost-effectiveness, and barrier properties of plastic materials for packaging various topical drug formulations. Plastic bottles are widely used for creams, lotions, gels, and ointments, offering good protection against moisture and light. The ability to incorporate various dispensing closures, such as pumps and flip-tops, further solidifies their market leadership. Guided by their versatility and widespread acceptance, plastic bottles remain the leading packaging format.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate, driven by the increasing prevalence of liquid topical formulations, including antiseptic solutions, medicated washes, and dermatological solutions. Innovations in packaging for liquid formulations, such as spray bottles and specialized droppers, are enhancing their usability. As the demand for convenient and effective liquid topical medications grows, this segment is poised for significant acceleration. Spurred by expanding liquid topical applications, this segment is charting significant growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, primarily driven by the region's large population, increasing healthcare expenditure, and the growing pharmaceutical manufacturing sector. Furthermore, the expansion of local pharmaceutical companies and contract manufacturing organizations contributes to its market leadership. Backed by a thriving pharmaceutical industry and large consumer base, the Asia Pacific region secures its leading market position.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by the presence of major pharmaceutical companies, strong investment in research and development for novel drug delivery systems, and a high adoption rate of advanced packaging solutions. The increasing demand for specialized and personalized topical medications further drives market expansion. Furthermore, stringent regulatory standards for drug packaging encourage innovation and the adoption of high-quality materials. Motivated by continuous innovation in pharmaceutical packaging, North America is poised for robust market growth.
Key players in the market
Some of the key players in Topical Drugs Packaging Market include AptarGroup, Constantia Flexibles, Gerresheimer, ProAmpac, RPC Group, Crown Holdings, Huhtamaki, Amcor, West Pharmaceutical Services, Sappi, Sealed Air, Berry Global, Mundipharma, Sonoco Products, and Shelby.
In May 2025, AptarGroup's launched a smart topical drug dispenser with precise dosing technology. The system enhances patient compliance for dermatological treatments, integrating IoT for usage tracking and regulatory compliance.
In March 2025, Gerresheimer released customizable plastic tubes for topical drugs with tamper-evident features. The tubes enhance safety and usability, catering to the growing demand for personalized medicine packaging solutions.
In February 2025, Berry Global launched a liquid applicator for topical drugs, improving ease of use for patients. The design ensures precise delivery and compatibility with various formulations, supporting pharmaceutical innovation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.